Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Multidisciplinary Rehabilitation Program for Treatment-Resistant Psychotic Forensic Patients: A Comparative Study [NA]
A completed comparative clinical trial evaluating a multidisciplinary rehabilitation program for treatment-resistant schizophrenia in forens…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: The Effectiveness of Lower Extremity Strength Training [NA]
This completed clinical trial evaluated the effectiveness of lower extremity strength training in patients with chronic schizophrenia. The s…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) [Phase 3]
Phase 3 trial evaluating dexmedetomidine for agitation associated with schizophrenia and bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Horyzons: Implementation and Integration in Clinical Practice [NA]
The Horyzons implementation study was terminated and results were posted on 2025-09-18. The trial focused on schizophrenia-spectrum disorder…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia [Phase 2]
This Phase 2 trial evaluated 10 mg and 30 mg doses of CVL-231 (emraclidine) in participants with schizophrenia; the study is completed and r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5) [Phase 3]
This is an open-label Phase 3 long-term study assessing safety, tolerability, and efficacy of KarXT in adult patients with schizophrenia; th…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: The Police-Mental Health Linkage System [NA]
Completed clinical trial update on the Police-Mental Health Linkage System sponsored by Columbia University, studying severe mental disorder…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of First Rank Symptoms (FRS) on Schizophrenia [NA]
This clinical trial update notes a completed study evaluating repetitive transcranial magnetic stimulation (rTMS) for treating first rank sy…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Comparison of the Effects of Physical Activity and Virtual Reality Training in Patients With Schizophrenia [NA]
Completed clinical trial comparing physical activity versus virtual reality training in patients with schizophrenia to evaluate effects on b…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia [Phase 2]
Phase 2 study evaluating the efficacy, safety, and pharmacokinetics of CPL500036 in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Effects of an Interpersonal Communication Skills Training Program on Medication Adherence of Schizophrenic Patients [NA]
A completed clinical trial evaluated whether an interpersonal communication skills training program improves medication adherence in people …
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia [Phase 1]
Phase 1 clinical trial update evaluating pharmacokinetics, safety, and tolerability of different formulations and dose strengths of Quarterl…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Remediation of Visual Perceptual Impairments in People With Schizophrenia [NA]
A completed clinical trial update reports remediation of visual perceptual impairments in individuals with schizophrenia or schizoaffective …
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: AI-assisted Masticatory Muscle Training in Patients With Schizophrenia [NA]
An AI-assisted masticatory muscle training clinical trial in schizophrenia patients, sponsored by Kaohsiung Medical University Chung-Ho Memo…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: The Effectiveness of Breathing Therapy in Patients With Schizophrenia [NA]
A completed clinical trial evaluated the effectiveness of breathing therapy in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Suicidal Behavior Among Schizophrenic Patients
A completed clinical trial update from Tanta University examining suicidal behavior in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Physical Fitness, Physical Activity Level, Depression and Quality of Life in Bipolar and Schizophrenia Patients
A completed clinical trial assessing physical fitness, physical activity level, depression, and quality of life in patients with bipolar dis…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia [Phase 3]
Phase 3 extension study of pimavanserin as adjunctive treatment for schizophrenia was terminated; results from the study were posted on 2025…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008) [Phase 2]
Phase 2 trial MK-8189-008 evaluates the efficacy and safety of MK-8189 in participants with an acute episode of schizophrenia. Results have …
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Physical Exercise on Simple Inflammatory Markers, Systemic Immune Inflammation Index, and Systemic Immune Response Index [NA]
A completed clinical trial evaluating whether physical exercise alters simple inflammatory markers and systemic immune indices in people wit…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: MBRS-Based Psychoeducation in Patients With Schizophrenia [NA]
This completed clinical trial evaluated MBRS-based psychoeducation for patients with schizophrenia, focusing on mindfulness-based strategies…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Time,Self and Spontaneous Mental Activities in Patients With Psychotic Disorders [NA]
A terminated clinical trial sponsored by University Hospital, Strasbourg, studying time, self, and spontaneous mental activities in patients…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Emotion and Motivation in Patients With Psychosis [NA]
This clinical trial update indicates that study NCT02853019, examining emotion and motivation in people with schizophrenia, has been termina…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use. [NA]
This completed study evaluated the CHAMPION-ECHO educational program to improve clozapine use in schizophrenia and schizoaffective disorder.…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Adjunctive iTBS for First-Episode Schizophrenia [NA]
The clinical trial evaluating adjunctive intermittent theta-burst stimulation for first-episode schizophrenia has completed.